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ABSTRACT 
Through a systematic review of data, a clinical affiliate hospital in south 
Mississippi identified opportunities to improve their treatment of adult patients presenting 
with or developing sepsis.  In response, the facility initiated an ongoing quality 
improvement program to revise their management of patients meeting sepsis and septic 
shock criteria, which included elements of the 2012 Surviving Sepsis Campaign (SSC) 
guidelines.  The purpose of this Doctor of Nursing Practice (DNP) project was to 
determine the current best practice recommendations for early adult sepsis management 
to assist with the implementation of an evidence-based adult sepsis guideline.  
The reviewed literature reported that the current best practice recommendations 
for early management of adult patients with sepsis include: (a) measurement of a serum 
lactate level within one hour of sepsis recognition and revaluation if the initial lactate 
level is  2 millimoles per liter (mmol/L); (b) obtaining blood cultures prior to the 
administration of antibiotic therapy; (c) administration of broad-spectrum antibiotics 
within one hour sepsis recognition; (e) rapid administration of 30 milliliters per kilogram 
(mL/kg) of intravenous (IV) crystalloid within one hour of sepsis recognition associated 
with hypotension or serum lactate   4 mmol/L; and (f) administration of vasopressors for 
hypotension during or after the initial fluid resuscitation to maintain a mean arterial 
pressure (MAP)  65 mmHg (Lester, Hartjes, & Bennett, 2018; Levy, Evans, & Rhodes, 
2018; Rhodes et al., 2017).  The best practice recommendations were presented to a panel 
of experts including (a) two Acute Care Nurse Practitioners (ACNPs), (b) two 
Emergency Department (ED) physicians, and (d) two Certified Registered Nurse 
Anesthetists (CRNA) at the facility where this project was conducted.  Sixty-six percent 
 iii 
of the panel of experts strongly agreed that the information provided was beneficial and 
relevant to their institution.  Additionally, 66% of the panel was provided with new 
information for the management of adult patients with sepsis based on the best practice 
recommendation presented.  Each member of the panel of experts agreed the best practice 
recommendations should be adopted. 
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CHAPTER I – INTRODUCTION 
Sepsis, a syndrome of life-threatening organ dysfunction induced by a 
dysregulated host response to infection, is a leading cause of critical illness and death in 
the United States (Paoli, Reynolds, Sinha, Gitlin, & Crouser, 2018; Singer et al., 2016).  
According to the Centers for Disease Control and Prevention (CDC, 2018), more than 1.5 
million Americans are diagnosed with sepsis each year; resulting in over 250,000 deaths.  
Currently, sepsis leads to 20% of all intensive care unit (ICU) admissions and is the most 
common cause of death in non-cardiac ICUs (Makic & Bridges, 2018).  In Mississippi, 
septicemia is the 10th leading cause of death according to the Mississippi State 
Department of Health (MDH, 2018), resulting in 636 fatal cases in 2016 (CDC, 
2017).  That same year, Mississippi had the second-highest national sepsis mortality rate 
of 19%, compared with an overall U.S. mortality rate of 10.7% (CDC, 2017).   
Despite advances in clinical practice, the incidence of sepsis continues to 
increase, as well as associated healthcare costs (Paoli et al., 2018).  According to Paoli et 
al. (2018), the healthcare cost of sepsis in 2013 was $24 billion, accounting for 13% of 
the total U.S. hospital cost but causing only 3.6% of hospital admissions.  In response to 
the increasing incidence of sepsis, in 2002, a collaboration between the Society of 
Critical Care Medicine and the European Society of Intensive Care Medicine known as 
the SSC was founded.  This campaign was founded to reduce mortality of sepsis and 
septic shock worldwide through (a) building awareness of sepsis, (b) improving 
diagnosis, (c) increasing the use of appropriate treatment, (d) educating healthcare 
professionals, (e) improving post-ICU care, (f) developing guidelines for care, and (g) 
implementing performance improvement programs (White, 2016).  Recently, this 
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organization has published updated guidelines for sepsis management in their 
International Guidelines for Management of Sepsis and Septic Shock: 2016, with an 
update published in 2018.  Prior versions of this guideline were published in 2004, 2008, 
and 2012 (Dellinger, Schorr, & Levy, 2017).  These guidelines recommend early 
recognition and initiation of evidence-based interventions, which include measurement of 
serum lactate levels, rapid administration of antibiotics, prompt fluid resuscitation in the 
presence of hypoperfusion, and vasopressor administration if indicated (Howell & Davis, 
2017; Makic & Bridges, 2018; Rhodes et al., 2017).   
Problem Description 
Through a systematic review of data, a clinical affiliate hospital located in south 
Mississippi identified opportunities to improve their treatment of patients presenting with 
or developing sepsis.  This facility is the main hospital for a collaborative network of 
medical institutions that provides regional health services across 19 surrounding counties.  
According to the MDH (2018), 136 reported deaths were caused by septicemia within 
this region in 2017, 99% of which occurred in adults 25 years and older, and 73% in 
those 65 years and older.  Additionally, the local county of the facility experienced the 
second-highest occurrence of sepsis mortality within the region, which included 20 
reported fatalities that year (MDH, 2018).  In response to this, the facility established an 
ongoing sepsis quality improvement program to revise their approach to the identification 
and treatment of patients meeting sepsis and septic shock criteria, which currently 
incorporates elements of the 2012 SSC guidelines.  Therefore, the purpose of this 
doctoral project was to determine the current best practice recommendations for early 
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adult sepsis management to assist an existing quality improvement program with the 
implementation of an evidence-based adult sepsis guideline.   
Available Knowledge 
During the initial phase of this project, a literature review was conducted utilizing 
online databases that included CINAHL, Cochrane Library, Elsevier Science Direct, 
EBSCO-host, Google Scholar, and PubMed.  Keywords and combinations of words used 
for the search included adult, sepsis, severe sepsis, septic shock, systemic inflammatory 
response syndrome, septicemia, surviving sepsis campaign, treatment, management, 
sepsis guidelines, sepsis bundles, and sepsis identification tools.  The initial search 
generated 156 articles from 2010 to 2019.  Study designs such as cohort studies, 
randomized control trials, prospective and/or retrospective studies, meta-analyses, and 
systematic reviews of adult patients ( 18 years old), published in the English language 
were required for inclusion.  Several of these studies were reviewed, and 17 met the 
inclusion criteria.  Exclusion criteria included irrelevant studies and insufficient data.  
Unless a study was significant to this project, the search was limited to literature 
published within the last five years.   
Sepsis Defined  
Since the initial definition was developed in 1991, the defining characteristics of 
sepsis have remained primarily unchanged (Singer et al., 2016).  In 2014, the Society of 
Critical Care Medicine and the European Society of Intensive Care Medicine reexamined 
the definition of sepsis.  A joint task force was created to review and update the clinical 
understanding of sepsis-induced changes in pathobiology.  The revised definition of 
sepsis differentiates from an uncomplicated infection, as sepsis is not a specific illness, 
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but rather a syndrome still not completely understood (Singer et al., 2016).  The revised 
terms and clinical criteria are published in the Third International Consensus Definitions 
for Sepsis and Septic Shock, also known as the Sepsis-3 Consensus.  The existing 
definitions are included in the Sepsis-2 Consensus that was published in 2001.  
  
Sepsis-2 Terminology   
 
Note. mmHg = millimeters of mercury.  mmol/L = millimoles per liter.  mm3 = cubic millimeter.  Adapted from “Assessment of 
Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)” by C. W. 
Seymour, V.X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea, A. Scherag, … D. C. Angus, 2016, Journal of the American Medical 
Association, 315, p. 762-774.  
 
  
Sepsis-3 Terminology 
Terminology Sepsis-2 Definitions and Criteria 
SIRS 
 
Systemic inflammatory response to a variety of clinical insults that is 
manifested as two or more of listed criteria.   
 
SIRS criteria include: (a) temperature > 38 or <36 C; (b) heart rate > 90 
beats/min; (c) respiratory rate >20 breaths/min; (d) white blood cell  
count >12,000/mm3 or <4,000/ mm3 or >10% immature bands.  
Sepsis Sepsis is an infection or suspected infection leading to the onset of 
SIRS. 
  
Severe 
Sepsis 
Sepsis complicated by organ dysfunction. 
Septic Shock Sepsis-induced hypotension persisting despite adequate fluid 
resuscitation 
Terminology Sepsis-3 Definitions and Criteria 
SIRS 
 
Sepsis  
Not incorporated into Sepsis-3 definitions. 
 
Sepsis is life-threatening organ dysfunction due to a dysregulated host 
response to infection. 
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Table 2 (continued).  
 
 
Note. MAP = mean arterial pressure. mmHg = millimeters of mercury.  mmol/L = millimoles per liter.  mm3 = cubic millimeter.  
Adapted from “Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic 
Shock (Sepsis-3)” by C. W. Seymour, V.X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea, A. Scherag, … D. C. Angus, 
2016, Journal of the American Medical Association, 315, p. 762-774.  
 
Clinical Manifestations 
The clinical manifestations of sepsis differ between patients, ranging from subtle 
to profound acute hemodynamic changes related to the cause of the infection, site of 
origin, and degree of organ dysfunction (Cecconi, Evans, Levy, & Rhodes, 2018).  The 
clinical presentation of symptoms is due to the body’s overwhelming response to the 
infection and the specific organ system involved (Gotts & Matthay, 2016).  These clinical 
manifestations include: (a) confusion, (b) delirium, (c) shortness of breath, (d) tachypnea, 
(e) tachycardia, (f) hypotension, (g) fever, (h) generalized pain, and (I) diaphoresis (CDC, 
2018; Gotts & Matthay, 2016). 
A multitude of infections can lead to the development of sepsis, resulting in 
varying degrees of organ dysfunction.  The occurrence of organ dysfunction may be 
subtle, making this life-threatening syndrome challenging to diagnose (Novosad et al., 
2016).  The organ systems most commonly affected by sepsis are the cardiovascular and 
respiratory systems (CDC, 2018).  Severe compromise of these systems results in 
Severe Sepsis  
 
Septic Shock  
Not incorporated into Sepsis-3 definitions.  
 
Septic Shock is sepsis in which particularly profound circulatory, 
cellular, and metabolic abnormalities substantially increase mortality.   
 
Criteria includes the requirement of vasopressor therapy to maintain a 
MAP  to 65 mmHg and an elevated lactate level greater that 2 
mmol/L after completion of adequate fluid resuscitation. 
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circulatory failure, myocardial dysfunction, elevated serum lactate, and development of 
acute respiratory distress syndrome (Cecconi et al., 2018; Gotts & Matthay, 2016).  
Best Practice Guidelines and Sepsis Bundles  
The SSC summarizes their guidelines as bundles, which outlines the main features 
of the recommendations for the diagnosis and treatment of sepsis (Rhodes et al., 2017).  
Jozwiak, Monnet, & Teboul (2016) describe bundles as a set of interventions associated 
with a disease process that, when used together, result in improved outcomes compared 
to implementing them individually.  The goals of bundles in the treatment of sepsis are to 
reduce mortality, improve outcomes, and ensure the application of evidence-based 
practices (Jozwiak, Monnet, & Teboul, 2016).  Bundles based on the 2012 SSC 
guidelines were for severe sepsis and septic shock related diagnosis and treatment, with 
the first to be completed within three hours and the second is to be completed within six 
hours of presentation or sepsis recognition, known as time zero (Levy, Evan, & Rhodes, 
2018).  In 2018, the SSC updated these bundles to incorporate new evidence, which now 
includes one bundle to be completed within one hour of time zero (Levy et al., 
2018).  This sepsis management outlined by the SSC is intended for use in the emergency 
department (ED), general hospital floors, and the ICU (Levy et al., 2018; Makic & 
Bridges, 2018; Rhodes et al., 2017). 
Before the 2018 update, the SCC recommended two measures for the 
reassessment of fluid status and tissue perfusion.  The first measure included a repeat 
focused exam after the initial resuscitation that involves assessing vital signs; 
cardiopulmonary, capillary refill, pulse and skin findings.  The second measure included: 
(a) measurement of central venous pressure (CVP), (b) measurement of central venous 
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oxygen saturation (ScvO2), (c) bedside cardiovascular ultrasound, and (d) assessment of 
fluid responsiveness with a fluid challenge (Makic & Bridges, 2018; Rhodes et al., 2017).  
According to the updated SSC guidelines, reassessment is now recommended to be 
completed thorough examination and evaluation of noninvasive variables, as well as 
invasive if available (Rhodes et al., 2017).  Further assessment of hemodynamic variables 
is recommended if necessary, to determine a diagnosis (Rhodes et al., 2017).  
  
Three- and Six-Hour Bundles  
 
Note. mL/kg = milliliters per kilogram.  mmol/L = millimoles per liter.  mmHg = millimeters of mercury.  Adapted from 
“Implementing Sepsis Bundles” by Jozwiak et al., 2016, Annals of Translational Medicine, 4(17), 332-340 
https://doi.org/10.21037/atm.2016.08.60 
 
  
One-Hour Bundle  
  
Three Hour Bundle 
1. Measure lactate level 
2. Obtain blood cultures prior to administration of antibiotics  
3. Administer broad-spectrum antibiotics  
4. Administer 30 mL/kg of IV crystalloid for hypotension or lactate  4 mmol/L  
Six Hour Bundle 
5. Apply vasopressors to maintain a MAP  65 mmHg.  
6. Reassessment of volume status and tissue perfusion with documentation of 
findings if hypotension persists after initial fluid volume replacement or the initial 
lactate was  4 mmol/L.  
7. Re-measure of lactate if initial lactate was elevated  
One Hour Bundle  
1. Measure lactate level.  
2. Obtain blood cultures prior to administration of antibiotics.  
3. Administer broad-spectrum antibiotics.  
4. Begin rapid administration of 30 mL/kg of crystalloid for hypotension or lactate  to 4 
mmol/L.  
5. Apply vasopressors if patient is hypotensive during or after fluid resuscitation to 
maintain MAP  65 mmHg.   
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Table 4 (continued) 
6. Frequent hemodynamic reassessments of patient’s fluid status through noninvasive 
measurements including vital sign assessment; cardiopulmonary, capillary refill,  
pulse, and skin findings; or bedside cardiovascular ultrasound 
7. Re-measure of lactate if initial lactate was elevated 
 
Note. mL/kg = milliliters per kilogram.  Mmol/L = millimoles per liter.  mmHg = millimeters of mercury.  Adapted from “The 
Surviving Sepsis Campaign Bundle: 2018 update” by Levy, M. M., Evans, L. E., & Rhodes, A., 2018, Intensive Care Medicine, 44(6), 
925–928. https://doi.org/10.1007/s00134-018-5085-0 
 
Implementation of these sepsis bundles has been associated with positive patient 
outcomes and reduced mortality (Jozwiak et al., 2016).  A systematic review and meta-
analysis of 50 observational studies published between 2006 and 2014 were conducted to 
determine the effects of performance improvement programs and compliance with sepsis 
bundles on sepsis mortality (Damiani et al., 2015).  This review reported a reduction in 
mortality from multiple included studies that performed improvement initiatives that 
adhered to sepsis bundles, with an overall odds ratio of 0.66 (95% CI: 0.61-0.72) 
(Damiani et al., 2015).  Another observational study conducted over an 11-month (N 
=167) period evaluated the impact of sepsis bundles on mortality.  This study reported a 
44% reduction in mortality of the population who received interventions outlined in 
sepsis bundles compared to the patients who did not, which correlated with a 4% 
decrease in the rates of admission to the ICU with every 10% increase in bundle 
compliance (Teles et al., 2017).  
In a multicenter study conducted in 218 ICUs between January 2005 and June of 
2012 (N =29,470), mortality was reported to be lower in locations with high sepsis 
bundle compliance (29.0%) compared to sites with low compliance (38.6%) (Levy et al., 
2014).  The conclusion of this multicenter study demonstrated a 25% relative risk 
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reduction in mortality rate associated with increased compliance with sepsis bundles 
(Levy et al., 2014).  In another multisite observation study consisting of three 
independent cohorts (N =15,000), improved mortality rates were reported with 
compliance to the three-hour sepsis bundle (Leisman et al., 2017).  In the first cohort, 
bundle compliant mortality was 22.6% compared to noncompliant of 26.5% (OR, 0.72 
[CI, 0.59-0.75], p <0.001).  In the second cohort, bundle compliant mortality was 13.4% 
compared to noncompliant of 17.8% (OR, 0.60 [CI, 0.44-0.80], p =0.001)).  In the third 
cohort, compliant bundle mortality was 18.1% compared to noncompliant of 21% (OR, 
0.84 [CI, 0.73-0.96], p =0.013) (Leisman et al., 2017).  
Serum Lactate.  The evaluation of serum lactate is an essential variable in the 
clinical management of sepsis-induced vasodilation (Makic & Bridges, 2018; Rhodes et 
al., 2017).  Serum lactate levels do not provide a direct calculation of tissue perfusion, but 
rather this laboratory value assists in identifying abnormalities and tissue hypoxia 
associated with this disease process (Rhodes et al., 2017; Singer et al., 2016).  Lactate 
levels that are greater than two mmol/L represent the presence of tissue hypoperfusion, 
and the severity of tissue hypoperfusion as this laboratory value increases (Makic & 
Bridges, 2018).  Evaluation of this laboratory value allows for an objective measurement 
of fluid status to be assessed, which can assist in guiding management in comparison to 
other indicators alone, such as urine output and other variables of clinical examination 
(Rhodes et al., 2017).  In a recent study conducted over five years (N =1,060) that 
evaluated lactate levels as a predictor of mortality, higher levels of serum lactate were 
recorded from subjects who did not survive (Ryoo et al., 2018). A median six-hour 
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lactate level of 4.6 mmol/L of nonsurvivors was reported in comparison to a level of 2.5 
mmol/L in the survivor group of this study (Ryoo et al., 2018).  
Source Control and Antimicrobial Therapy.  Identifying the source of infection is 
essential to appropriately provide care to this population (Rhodes et al., 2017).  Upon 
presentation, a quick assessment should be completed to identify and rule out likely 
sources of infection (Gotts & Matthay, 2016; Makic & Bridges, 2018).  After locating the 
source, the responsible infectious pathogen should be identified through routine blood, 
sputum, and urine cultures (Levy et al., 2018; Rhodes et al., 2017).  Obtaining these 
samples should be completed before starting intravenous (IV) antibiotic therapy in 
patients with suspected sepsis; as long as this does not delay treatment (Levy et al., 2018; 
Rhodes et al., 2017).  The SSC recommends that IV antibiotics be initiated as soon as 
possible, with a goal administration within one hour of identifying sepsis or sepsis shock 
(Levy et al., 2018; Makic & Bridges; 2018; Rhodes et al., 2017).  The rapid initiation of 
antibiotics has been associated with improved outcomes and reduced mortality in adult 
patients with sepsis (Johnston et al., 2017; Rhodes et al., 2017).  A systematic review and 
meta-analysis consisting of 10 quantitative studies published between 1990 and 2016 was 
conducted to determine the effect of antimicrobial administration on sepsis patients in 
tertiary care.  This review reported a 33% reduction in mortality odds for patients who 
received IV antibiotics within one hour of sepsis recognition compared to the population 
who experienced delayed administration (OR, 0.67 [95% CI, 0.59-0.75]) (Johnston et al., 
2017).  Additionally, in a retrospective cohort study completed at a 656-bed medical 
institution (N =3,929) to determine the effects of initial antibiotic administration with the 
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progression of sepsis, each hour that antimicrobial administration was delayed associated 
with an 8% increase in progression of septic shock (Whiles, Deis, & Simpson, 2017).  
Fluid Resuscitation and Vasopressors. Early fluid resuscitation is a vital part of 
sepsis management which supports tissue perfusion and hemodynamic components (Levy 
et al., 2018; Makic & Bridges, 2018; Rhodes et al., 2017).  Delays in fluid resuscitation 
are related to poor patient outcomes, including acute organ injury, presenting as 
hypotension, and elevated serum lactate (Gotts & Matthay, 2016).  Initial resuscitation 
for induced hypoperfusion recommended by the SSC includes the administration of 30 
mL/kg of IV crystalloid fluid within 1 hour of patient presentation or sepsis recognition 
that is associated with hypotension or serum lactate  4 mmol/L (Levy et al.,2018; 
Rhodes et al., 2017).  In an observational cohort study that was conducted over a 13-
month period (N =1800) to determine the effects of early fluid resuscitation on mortality, 
early initiation of fluid administration was associated with a reduction in mortality for 
severe sepsis and septic shock patients (OR 0.63; 95% CI 0.46 to 0.86) (Leisman et al., 
2016).  After the initial resuscitation, reassessments are recommended to determine the 
need for additional fluid requirements (Makic & Bridges, 2018).  The recommended 
reassessments include analyzing (a) heart rate, (b) blood pressure, (c) oxygen saturation, 
(d) respiratory rate, (e) temperature, and (f) urine output (Levy et al., 2018; Makic & 
Bridges, 2018; Rhodes et al., 2017). 
If hypotension continues after initial fluid resuscitation, administration of 
vasopressors is necessary to maintain a MAP  65 mmHg (Gotts & Matthay, 2016; 
Rhodes et al., 2017).  The first vasopressor recommended for treatment of continued 
hypotension associated with sepsis is norepinephrine, with the addition of vasopressin if 
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the target MAP is not met by norepinephrine alone (Rhodes et al., 2017).  The 
administration of norepinephrine increases MAP through systemic vasoconstriction, with 
little changes in heart rate and stroke volume (Gotts & Matthay, 2016; Levy et al., 
2018).  If the presence of shock continues after starting vasopressor therapy, 
hemodynamic variables of the individual should be assessed, including the evaluation of 
cardiac function. (Makic & Bridges, 2018; Rhodes et al., 2017).  In a systematic review 
and meta-analysis of randomized control trials conducted over a 4-month period from 
March 2014-June 2014 of 32 trials (n=3544) that compared norepinephrine to dopamine 
was associated with a decreased all-cause mortality (RR 0.89 [95% Cl 0.81-0.98).  No 
advantage to norepinephrine over other vasopressors was reported on length of stay 
(median 15 days, range 7-52).  Norepinephrine was associated with a lower risk of major 
events for major adverse events (RR 0.34 [95% Cl 0.14 0.84) (Avni et al., 2015).  
Screening and Improvement Initiatives  
Challenges exist in screening for sepsis, as there are no exact clinical criteria 
established for identifying this disorder (Seymour et al., 2016; Singer et al., 2016).  
Measures that assist with rapid recognition can aid in reducing unnecessary delays in 
treatment initiation (Seymour et al., 2016).  Early identification of sepsis has been 
accomplished through implementing screening tools, such as early warning scores that 
provide list assessment parameters and laboratory values linked to presenting 
manifestations of this condition (Seymour et al., 2016; Singer et al., 2016; Torsvik et al., 
2016).  The SSC recommends that performance improvement programs aimed at earlier 
identification be implemented within hospitals through formal screening programs 
(Rhodes et al., 2017).  
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Despite the challenge of identifying at-risk patients, multiple early warning 
systems have been developed that incorporate measures commonly for the criteria of 
SIRS (Serafim, Gomes, Salluh, & Póvoa, 2018).  These criteria assess irregularities in 
temperature, heart rate, respiratory rate, and white blood cell (WBC) count (Singer et al., 
2016).  In the Third International Consensus, experts from the gathered task force 
included recommendations for a new measure of screening at-risk patients, termed 
qSOFA for quick Sequential Organ Failure Assessment (Singer et al., 2016).  This tool is 
not meant to be used as a sole measure for sepsis development, but rather a tool to assist 
clinicians in managing care. (Singer et al., 2016).  This screening tool assesses altered 
mental status, systolic blood pressure of 100 mmHg or less, and respiratory rates of 22 or 
higher.  The qSOFA has been reported to improve screening programs in multiple 
settings through incorporating a simple bedside criterion that does not involve evaluation 
of laboratory values (Singer et al., 2016).  
In a systematic review and meta-analysis that included 23 studies (N = 147,000), 
positive qSOFA scores had a higher specificity than the routine screening tools for 
effectively detecting early in-patient mortality (0.83 vs. 0.29) (Song, Sin, Park, Shim, & 
Lee, 2018).  When compared to the SIRS criteria, qSOFA was reported to be a limited 
predictive tool for adverse outcomes (Song et al., 2018).  A meta-analysis, consisting of 
10 studies (N = 229,480) conducted from February 2016 to June of 2017, compared 
qSOFA and SIRS for their sensitivity or specificity in diagnosing sepsis.  This review 
concluded the SIRS was superior for diagnosing sepsis (RR, 1.32; 95% CI, 0.40-
2.24; P < .0001), but the qSOFA was a better predictor of hospital mortality (RR, 0.03; 
95% CI, 0.01-0.05; P = .002) (Serafim et al., 2018).  
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Transferring evidence-based measures into clinical practice can be a difficult 
process, as barriers in interdisciplinary members and departments may exist (Grek et al., 
2017).  Adherence to SSC guidelines varies with increased rates of compliance associated 
with hospitals who participate in performance improvement programs (Demiani et al., 
2015; Levy et al., 2014).  The SSC currently recommends that facilities participate in 
interdepartmental improvement programs for sepsis, as these have shown to improve 
patient outcomes (Jozwiak et al., 2016; Levy et al., 2014; Rhodes et al., 2017).  In the 
multicenter study conducted by Levy et al., every reported 10% increase in sepsis 
performance bundle compliance and additional quarter of participation in the SSC 
performance improvement initiatives was associated with 0.7% reduction in sepsis 
mortality (p < 0.001) (2014).  Successful implementation of performance programs 
includes sepsis guideline development and implementation, data collection, and targets 
guidelines for evaluation.  Quality improvement initiatives are a valuable tool for 
promoting improvements in clinical practice and positive patient outcomes (Demiani et 
al., 2015; Rhodes et al., 2017).  
Rationale 
The evidence-based framework used to guide this project was the Donabedian 
model.  This conceptual framework is a model developed by Adevis Donabedian that has 
been used for decades to advance and evaluate health services.  This model outlines three 
approaches to evaluating health care that include structure, process, and outcome 
(Brosnan, 2012).  This conceptual framework applies to the proposed project through 
assistance with the modification of structural components and implementation of 
processes to improve outcomes of one population at the system level.  
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Structure refers to the organizational support and the environment in which care is 
rendered.  Structural components include hospital facilities, proficient personnel, 
equipment, and other operation factors (Brosnan, 2012).  The structures of this project 
included: (a) adult units of a regional Level II Trauma Center and (b) the facilities Sepsis 
Advisory workgroup, administrative staff, physicians, and nurses.   
Process refers to the interactions between practitioners and patients throughout the 
delivery of care, which should reflect current standards of clinical practice.  Diagnostic 
testing, diagnosis of conditions, clinical results, prescribed treatment regiments, and types 
of patient education are all process characteristics (Brosnan, 2012).  The process of this 
project included a best practice recommendation to assist with developing an evidence-
based guideline for early adult sepsis treatment.   
Outcomes are the result of implementing changes in the structures and processes, 
which includes the measurable change in the status of the patient as the result of the 
delivered healthcare.  Outcome components validate the effectiveness and quality of the 
care rendered (Brosnan, 2012).  The outcome of this project included increased 
knowledge of an expert panel after an in-service that has the potential to improve patient 
outcomes.   
Specific Aims 
The purpose of this DNP project was to determine the current best practice 
recommendations for early adult sepsis management to assist an existing quality 
improvement program with the implementation of an evidence-based adult sepsis 
guideline.  Effective management of sepsis through the implementation of evidence-
based clinical guidelines has shown to decrease hospital stays, improve patient outcomes, 
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increase financial savings, and, ultimately, lead to lower mortality rates (Damiani et al., 
2015; Levy et al., 2014; Torsvik, 2016).  Therefore, the goal of this project was to reveal 
relevant evidence for early adult sepsis management to assist a Level II Trauma Center in 
south Mississippi with improving adult patient outcomes and reducing the mortality of 
sepsis.  
DNP Essentials 
According to the American Association of Colleges of Nursing (AACN, 2006), 
the DNP Essentials outline eight central competencies for all advanced nursing practice 
roles.  Through the completion of this doctoral project, all essentials were met and are 
expanded upon in Appendix F.  The competencies highlighted in this doctoral project 
include Essentials I, II, and VIII. 
Summary 
 Sepsis is a medical emergency that is similar to stokes and polytrauma, which 
necessitate prompt identification and treatment initiation.  Screening initiatives for the 
early recognition of patients with sepsis or potential infections are essential to initiate 
appropriate treatment measures.  The critical points for sepsis management by the SSC 
are outlined in the updated one-hour bundle published in 2018.  Numerous studies have 
revealed that the implementation of interventions outlined by the SCC is associated with 
improved patient outcomes and reduced rates of sepsis mortality.  Additionally, quality 
improvement initiatives are a valuable tool for promoting improvements in clinical 
practice and positive patient outcomes. 
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CHAPTER II – METHODS 
Context  
The facility where this doctoral project was conducted at is the chief hospital for a 
collaborative network of medical institutions that provides regional health services across 
19 surrounding counties.  During the time of this project, the 545-bed facility contained 
400 general in-patient beds and 52 ED beds; which experienced approximately 2,800 in-
patient admissions and 7,300 ED visits each month.  According to the MDH (2018), 136 
reported deaths were caused by septicemia within this region in 2017, 99% of which 
occurred in adults 25 years and older and 73% in those 65 years and older.  Additionally, 
the local county of the facility experienced the second-highest occurrence of sepsis 
mortality within the region, which included 20 reported fatalities that year (MDH, 2018).  
The demographics of the local region during this best practice project were 68.3% 
Caucasian, 28.9% African American, 2.4% Hispanic, and 0.4% from other races (MDH, 
2018).   
Intervention, Study of the Intervention, and Measures   
During the initial phase of the intervention, a comprehensive literature review was 
conducted to analyze the current evidence and best practice guidelines for early adult 
sepsis management.  The gathered literature was then organized and recorded into a 
literature matrix, as shown in Appendix A, based on the year published and level of 
evidence.  Among the literature reviewed, authors agreed that sepsis and septic shock are 
medical emergencies that are similar to stokes and polytrauma, which necessitate prompt 
identification and treatment initiation (Lester et al., 2018; Levy et al., 2018; Rhodes et al., 
2017).  The reviewed literature reported that the current best practice recommendations 
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for the early management of adult patients with sepsis include seven essential 
components.  The first component includes measuring a serum lactate level within one 
hour of sepsis recognition and revaluating the serum lactate measurement if the initial 
level is  2 mmol/L.  Additionally, the current best practice recommendations include 
obtaining blood cultures prior to the administration of antibiotic therapy and 
administering broad-spectrum antibiotics within one-hour sepsis recognition.  The next 
components of these recommendations include the rapid administration of 30 mL/kg of 
IV crystalloid within one hour of sepsis recognition associated with hypotension or serum 
lactate  4 mmol/L; and administering vasopressors for hypotension during or after the 
initial fluid resuscitation to maintain a MAP  65 mmHg.  The last component includes 
frequent reassessments of fluid status are recommended to be conducted through 
noninvasive measurements including, vital sign assessment; cardiopulmonary, capillary 
refill, pulse, and skin findings; and bedside cardiovascular ultrasound (Lester et al., 2018; 
Levy et al., 2018; Rhodes et al., 2017). 
A report of findings was created, as shown in Appendix B, which compared 
components of the facilities ongoing quality improvement program to the current best 
practice recommendations gathered.  The report of findings was then presented to a panel 
of experts for review and evaluation.  The expert panel included: (a) two ACNPs, (b) two 
ED physicians, and (d) two CRNAs at the facility.  The experts were selected for the 
panel due to their direct role in providing care to adult patients with sepsis, their 
extensive knowledge, and the ability to provide feedback on the current topic.  The best 
practice recommendations and supporting evidence were presented to each participant of 
the expert panel in person.   
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Following the oral presentation, the members of the panel were presented with an 
evaluation tool, as shown in Appendix C, to obtain feedback on the information provided.  
The first question of the evaluation tool assessed whether the presented information 
regarding the current best practice guidelines for sepsis management was new to each 
participant.  The second question assessed whether the information provided was 
beneficial.  The third question assessed whether the provided information was relevant to 
the participants’ institution.  Lastly, the fourth question assessed whether the members of 
the expert panel would consider adopting the best practice recommendation provided.  
The participates were instructed not to include any identifying information on the 
completed evaluation tools to keep results confidential.  Data was kept on a personal 
computer that required a password for entry and files were kept in a locked filing cabinet.  
After completion of this project, all input data was permanently destroyed from the 
personal computer, and all files were shredded.   
Analysis  
After presenting the best practice recommendations to the expert panel in person, 
qualitative data was collected through an evaluation tool, as shown in Appendix C.  All 
six participants completed the provided questionnaires.  Obtained responses were 
compiled, as shown in Table 5, to analyze feedback and concerns.  The data gathered was 
analyzed qualitatively to assess whether the best practice recommendations provided 
were beneficial and relevant to the institution where this doctoral project was conducted.    
Ethical Considerations  
This project was conducted at a clinical affiliate hospital after approval from the 
University of Southern Mississippi (USM) Institutional Review Board (IRB) (Protocol 
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#19060705, Appendix D).  An ethical consideration for this project involved whether or 
not the panel of experts would not consider adopting the best practice recommendation 
provided.  Supporting evidence suggests that implementation of the best practice 
recommendations, which includes the one-hour bundle for sepsis management, has been 
correlated with improved patient outcomes and reduced rates of sepsis mortality.  The 
methods used to formulate these best practice recommendations did not result in any 
direct patient contact.   
Summary  
The purpose of this DNP project was to determine the current best practice 
recommendations for early adult sepsis management to assist an existing quality 
improvement program with the implementation of an evidence-based adult sepsis 
guideline.  The best practice recommendations gathered were presented to a panel of 
experts for review and evaluation.  An evaluation tool was utilized to gather feedback 
from the participants of this panel. 
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CHAPTER III  - RESULTS 
Overview 
The purpose of this DNP project was to determine the current best practice 
recommendations for early adult sepsis management to assist an existing quality 
improvement program with the implementation of an evidence-based adult sepsis 
guideline.  The gathered best practice recommendations and supporting evidence was 
presented to an expert panel that included two ACNPs, two ED physicians, and two 
CRNAs employed at the facility where the project was conducted.  The panel participants 
were selected due to their direct role in providing care to adult patients with sepsis, their 
extensive knowledge, and the ability to provide feedback on the current topic.  Following 
the presentation, the participants were presented with an evaluation tool, as shown in 
Appendix C, to obtain feedback on the information provided.  Four panel members 
strongly agreed that the presented information was beneficial and relevant to their 
institution, while the other two members agreed with these statements.  Additionally, 
each panel member was willing to adopt the best practice recommendation at their 
facility.  Out of the six participants, two answered no to the first question, which sought 
to determine whether the presented information regarding the updated 2018 bundle for 
sepsis management was new to each member.  The results obtained via the evaluation 
tool reported that four members of the expert panel were unaware of the 2018 bundle 
update, which resulted in four members of the panel being provided with new 
information for the management of adult patients with sepsis based on the best practice 
recommendations presented.  
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Panel of Experts Responses on the Presented Best Practice Recommendations  
Evaluation Tool 
Questions 
Panelist 
#1 
Panelist 
#2 
Panelist 
#3 
Panelist 
#4 
Panelist 
#5 
Panelist 
#6 
Is this 
presentation 
regarding the 
updated 2018 
bundle for sepsis 
management new 
to you? 
Yes Yes No No Yes Yes 
Was the 
information 
provided 
beneficial? 
Strongly 
Agree 
Strongly 
Agree 
Agree 
 
Agree Strongly 
Agree 
Strongly 
Agree 
Was the 
information 
provided relevant 
to your 
institution? 
Strongly 
Agree 
Strongly 
Agree 
Agree Agree Strongly 
Agree 
Strongly 
Agree 
Would you 
consider adopting 
these best practice 
recommendations?
  
Yes Yes Yes Yes Yes Yes 
 
Summary 
Qualitative data found via the evaluation tool showed that 66.67% of the expert 
panel strongly agreed that the information provided was beneficial and relevant to their 
institution.  Additionally, 66.67% of the panel were provided with new information for 
the management of adult patients with sepsis based on the best practice recommendation 
presented.  Each member of the expert panel agreed the best practice recommendations 
should be adopted, with one member suggesting that “fluid administration amounts be 
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adjusted based on the individual patient’s history.”  The panel participants provided no 
further feedback.   
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CHAPTER IV – DISCUSSION 
Summary 
Transforming healthcare systems to meet the demand for safe, quality, and 
affordable care is accomplished by incorporating new knowledge into clinical practice 
(White, 2016).  Implementation of evidence-based practices guidelines through quality 
improvement initiatives are means of not only providing beneficial advances in patient 
care, but effective structural changes that result in improved organizational efficiency and 
lower costs of health care delivery (Baron, Metnitz, Rhodes, & Kozek-Langenecker, 
2017).  Additionally, evidence-based practices assist with reducing ineffective 
interventions that can produce adverse patient outcomes (Baron, 2017; Lowell, 
2017).  The purpose of this project was to determine the current best practice 
recommendations for early adult sepsis management to assist an existing quality 
improvement program with the implementation of an evidence-based adult sepsis 
guideline.  The literature review conducted during the initial phase of this project 
indicated that improving the early identification and treatment of sepsis is essential to 
reducing the morbidity and mortality in this population (Rhodes et al., 2017; Singer et al., 
2016).  Prompt initiation of evidence-based interventions have shown to (a) decrease the 
length of hospital stays, (b) reduce ICU admissions, (c) improve overall patient 
outcomes, (d) increase financial savings, and (e) and ultimately lead to lower mortality 
rates within this population (Damiani et al., 2015; Levy et al., 2014; Torsvik et al., 2016).  
By synthesizing the current evidence and providing best practice recommendations, this 
doctoral project has the potential to improve the management of adult patients with sepsis 
and improve patient outcomes.   
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Interpretation 
Best practice recommendations for the early management of adult patients with 
sepsis were individually presented to an expert panel in-person, which included two 
ACNPs, two ED physician, and two CRNAs.  Throughout the completion of this project, 
multiple DNP Essentials were met, each of which are shown and expanded upon in 
Appendix F (AACN, 2006).  Following the presentation, the panel of experts were given 
the opportunity to provide feedback via an evaluation tool, shown in Appendix C.  Based 
on the feedback obtained, the panel participants were receptive to the recommendations 
provided.   
Limitations 
Limitations of this study included a small sample size of panel members selected 
to evaluate the purposed best practice recommendations.  With the inclusion of only six 
participants, a larger panel of experts may have proved beneficial to the evaluation 
process of this project.  Another limitation is the potential for a biased presentation due to 
the extensive research conducted prior to the presentation to the expert panel.  
Additionally, the implications of the findings were limited to the one site of this project 
located in south Mississippi.    
Conclusion 
Sepsis and septic shock are medical emergencies that are similar to stokes and 
polytrauma, which necessitate prompt identification and treatment initiation (Lester et al., 
2018; Levy et al., 2018; Rhodes et al., 2017).  In the ever-evolving world of health care, 
providers must be up to date with current evidence-based practice guidelines in order to 
reduce healthcare costs and improve patient outcomes (Baron et al., 2017; White, 
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2016).  Incorporating current best practice recommendations published by the SSC have 
shown to (a) decrease the length of hospital stays, (b) reduce ICU admissions, (c) 
improve overall patient outcomes, (d) increase financial savings, and (e) ultimately lead 
to lower mortality rates within this population (Damiani et al., 2015; Levy et al., 2014).  
The current best practice recommendations for the early management of adult patients 
with sepsis include seven essential components.  The first component includes measuring 
a serum lactate level within one hour of sepsis recognition and revaluating the serum 
lactate measurement if the initial level is  2 mmol/L.  Additionally, the current best 
practice recommendations suggest obtaining blood cultures prior to the administration of 
antibiotic therapy and administering broad-spectrum antibiotics within one-hour sepsis 
recognition.  The next components of these recommendations include the rapid 
administration of 30 mL/kg of IV crystalloid within one hour of sepsis recognition 
associated with hypotension or serum lactate  4 mmol/L; and administering 
vasopressors for hypotension during or after the initial fluid resuscitation to maintain a 
MAP  65 mmHg.  The last component includes frequent reassessments of fluid status 
are recommended to be conducted through noninvasive measurements including, vital 
sign assessment; cardiopulmonary, capillary refill, pulse, and skin findings; and bedside 
cardiovascular ultrasound (Lester et al., 2018; Levy et al., 2018; Rhodes et al., 2017). 
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APPENDIX A -- Literature Matrix  
Author/Year/ 
Title 
Design/ 
Level 
Sample/ 
Data  
Collection  
Major Outcomes/ 
Measurements  
Findings Conclusions/ 
Recommendations 
Avni et al., 2015 
 
Vasopressors for 
the Treatment of 
Septic Shock: 
Systematic 
Review and 
Meta-Analysis 
Systematic 
review and 
meta-analysis of 
randomized 
control trials 
(RCTs) 
 
Level I  
32 trials (n = 
3,544) included. 
 
Data extracted 
between 
03/2014 and 
06/2014 by two 
independent 
reviewers. 
 
Exclusion 
criteria: studies 
that assess 
different 
dosages or 
schedules of the 
same 
vasopressors.  
Primary: 
• All-cause 
mortality at 28 
days 
 
Secondary:  
• Length of ICU 
and/or hospital 
stays in live, 
discharged 
patients 
• Ventilator free 
days 
• Vasopressor 
free days 
• Hemodynamic 
profiles  
• Adverse events 
• Compared to 
dopamine (n = 866, 
450 events), 
norepinephrine (n = 
832, 376 events) 
was associated with 
decreased all-cause 
mortality, RR 0.89 
(95% Cl 0.81-0.98) 
• No advantage of 
norepinephrine to 
other vasopressors 
on LOS (median 15 
days, range 7-52) 
• Norepinephrine 
was associated with 
lower risk for 
major adverse 
events, RR 0.34 
(95% CI 0.14 0.84, 
I
2
= 0%, n = 3) and 
cardiac 
dysrhythmias, RR 
0.48 (95% CI 0.40–
0.58, I
2 
= 30%, n = 
4) compared to 
dopamine 
• No mortality 
benefit was 
demonstrated for 
the comparisons of 
norepinephrine and 
epinephrine, 
phenylephrine, or 
vasopressin 
• Norepinephrine 
should be 
regarded as the 
first-line 
vasopressor in 
the treatment of 
septic shock 
• Improved 
benefits, better 
hemodynamic 
profile and 
reduced adverse 
reactions 
experienced with 
norepinephrine 
over dopamine 
• Trials to guide 
recommendations 
for other 
vasopressors are 
needed 
Damiani et al., 
2015  
 
Effect of 
Performance 
Improvement 
Programs on 
Compliance with 
Sepsis Bundles 
and Mortality: A 
Systematic 
Review and 
Meta-Analysis of 
Observational 
Studies 
Systematic 
review and 
meta-analysis of 
observational 
studies  
 
Level III 
50 
observational 
studies 
published 
between 2006 
and 2014.  
 
Data extracted 
by two 
independent 
reviews. 
Evaluate the 
impact of 
performance 
improvement 
programs on 
compliance with 
Surviving Sepsis 
Campaign (SSC) 
guideline-based 
bundles and/or 
mortality. 
Performance 
improvement programs 
were associated with:  
• Increased 
compliance with 
the complete 6-
hour bundle (OR = 
4.12 [95% 
confidence interval 
2.95-5.76]) and the 
complete 24-hour 
bundle (OR = 2.57 
[1.74-3.77]) 
• Reduced mortality 
(OR = 0.66 [0.61-
0.72]) 
• Performance 
improvement 
programs 
increase 
compliance with 
the SSC 
guideline-based 
bundle targets 
and are 
associated with 
decreased 
mortality in 
patients with 
sepsis, severe 
sepsis or septic 
shock  
Gu, Zhang, & 
Bakker, 2015 
 
Early lactate 
clearance-guided 
therapy in 
patients with 
sepsis: a meta-
analysis with 
trial sequential 
Meta-analysis 
of random 
controlled trials  
 
Level I 
4 Random 
Controlled 
Trials (n=547).  
Evaluation of early 
lactate clearance-
guided therapy.  
 
Primary outcome:  
• All-cause 
mortality 
 
Secondary 
outcome:  
• Early lactate 
clearance-guided 
therapy was 
associated with a 
reduction in 
mortality (RR -.65, 
95 % Cl o.49-0.85, 
p = 0.002) 
• Early lactate 
clearance-guided 
• Use of lactate 
clearance as a 
goal to guide 
early therapy is 
associated with a 
reduction in the 
risk of health in 
adult patients 
with sepsis 
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analysis of 
randomized 
controlled trials 
• Length of 
hospital and 
ICU stay 
therapy had no 
effect on length of 
hospital stay 
(weighted mean 
difference, WMD –
0.13 days, 95 % CI 
–4.58 to 4.31, three 
RCTs [2, 3, 5]) and 
length of ICU stay 
(WMD)–1.54 days, 
95 % CI –3.22 to 
0.15, four RCTs 
[2–5] 
• Further research 
is needed, as the 
underlying 
mechanisms by 
which lactate 
therapy benefit 
septic patients 
remains to be 
investigated  
Johnston et al., 
2017 
 
Effect of 
Immediate 
Administration 
of Antibiotics in 
Patients with 
Sepsis in 
Tertiary Care: A 
Systematic 
Review and 
Meta-analysis 
Systematic 
review and 
meta-analysis  
 
Level III 
11 studies 
consisting of 1 
randomized 
control trial, 6 
retrospective 
cohort studies, 3 
prospective 
cohort studies, 
and 1 pre-post 
observational 
study conducted 
between 2005-
2013 
(n=20,348). 
 
Data extracted 
by two 
independent 
authors. 
Primary: In-
hospital mortality 
of septic patients 
presenting to the 
emergency 
department with 
immediate (within 
1 hour) antibiotic 
administration to 
later administration 
(> 1 hour). 
• 10 studies reported 
in-hospital 
mortality between 
4%-34% immediate 
administration and 
between 19%-43% 
mortality for later 
administration  
• The pooled results 
suggest a 
significant 33% 
reduction in 
mortality odds for 
immediate (within 
1 hour) compared 
with later (>1 hour) 
antibiotic 
administration (OR, 
0.67 [95% CI, 
0.59– 0.75]) in 
patients with sepsis 
• Early recognition 
of sepsis with 
immediate 
administration (< 
1 hour) of 
antibiotics seems 
to reduce patient 
mortality 
Jozwiak, 
Monnet, & 
Teboul, 2016 
 
Implementing 
Sepsis Bundles 
Expert opinion  
 
Level VII 
N/A  Brief summary of 
the defining 
characteristics, 
benefits, limits, 
and pitfalls of 
sepsis bundles. 
N/A • Implementation 
of sepsis bundles 
results in 
decreased 
mortality and 
improved 
outcomes of 
patients with 
septic shock  
• Benefits of sepsis 
bundles depend 
on compliance 
and educational 
programs 
Leisman et al., 
2016 
 
Association of 
Fluid 
Resuscitation 
Initiation Within 
30 Minutes of 
Severe Sepsis 
and Septic Shock 
Recognition with 
Reduced 
Mortality and 
Length of Stay 
Prospective 
observational 
cohort study  
 
Level III 
Urban tertiary 
care center. 
 
Severe sepsis or 
septic shock 
patients 
recorded in a 
performance 
improvement 
database (n = 
1,866) from 
09/2013-
09/2014. 
Primary: 
• Determine the 
association of 
initiating 
intravenous 
fluid 
resuscitation 
within 30 
minutes of 
severe sepsis or 
septic shock 
identification 
in the ED with 
in-hospital 
mortality  
Secondary: 
• To calibrate the 
30-minute 
specification by 
assessing the 
• Primary analysis: 
64% (n = 1193) of 
subjects received 
intravenous fluid 
within 30 minutes 
• Mortality was 
lower in the 30-
minute group (159 
[13.3%] vs. 123 
[18.3%]; 95% 
confidence interval 
[CI] 1.4% to 8.5%) 
• Median hospital 
length of stay was 
also reduced in the 
30-minute group (6 
days [95% CI 6 to 
7] versus 7 days 
[95% CI 7 to 8]) 
• The initiation of 
intravenous fluid 
resuscitation is 
associated with 
improved 
mortality which 
could be used as 
a performance 
indicator in 
severe sepsis and 
septic shock 
management 
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relationship 
between 
whether 
intravenous 
fluid 
resuscitation 
initiated within 
30 minutes, 31 
to 60 minutes, 
61 to 180 
minutes, or 
greater than 
180 minutes 
and in-hospital 
mortality in an 
adjusted model 
• IV fluid 
administration 
within 30 minutes 
was associated with 
lower mortality 
(odds ratio 0.63; 
95% CI 0.46 to 
0.86) and 12% 
shorter length of 
stay (95% CI 1.02 
to 1.27) 
• Secondary 
Analysis: Mortality 
increased with later 
IV fluid 
resuscitation 
initiation: 13.3% 
(30 minutes) versus 
16.0% (31 to 60 
minutes) versus 
16.9% (61 to 180 
minutes) versus 
19.7% (>180 
minutes) 
Leisman et al., 
2017 
 
Survival Benefit 
and Cost Savings 
from 
Compliance with 
a Simplified 3-
Hour Sepsis 
Bundle in a 
Series of 
Prospective, 
Multisite, 
Observational 
Cohorts: Critical 
Care Medicine 
Prospective 
multisite 
observational 
study  
 
Level IV 
Three 
independent 
cohorts, from a 
single U.S. 
health system.  
 
Cohort 1: five 
tertiary and six 
community 
hospitals in 
2012 (n=5,819). 
 
Cohort 2: 
Single tertiary, 
academic 
medical center 
in 
2014(n=1,697). 
 
Cohort 3: five 
tertiary and four 
community 
hospitals in 
2015 (n=7,239). 
Primary  
• In-hospital 
mortality 
• Total direct 
cost in cohorts 
2 and 3 
Cohort 1 
• Bundle 
compliance: 1,050 
(18%) 
• Mortality: 604 
(22.6%) versus 834 
(26.5%); Cl, 0.9-
7.1%; adjusted 
odds ratio, 0.72; CI, 
o.61-0.86; p value 
is less than 0.001 
Cohort 2 
• Bundle 
compliance: 739 
(43.5%) 
• Mortality: 99 
(13.4%) versus 171 
(17.8%); CI, 1.0-
7.9%; adjusted 
odds ratio, 0.60; CI 
0.44-0.80; p value 
is equal to 0.001 
• Mean costs: 
$14,845 versus 
$20,056; CI, -
$4,798 to -5,624; 
adjusted , -$2,851; 
CI, -$4880 to -822; 
p value is equal to 
0.006 
Cohort 3 
• Bundle 
compliance: 2,115 
(29.2%)  
• Mortality: 383 
(18.1%) versus 
1,078 (21.0%); CI, 
0.9–4.9%; adjusted 
odds ratio, 0.84; CI, 
0.73–0.96; p value 
is equal to 0.013 
• Mean costs: 
$17,885 versus 
$22,108; CI, –
• Bundle 
compliance from 
three 
independent 
cohorts was 
associated with 
reduced mortality 
and improved 
cost savings  
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$2,783 to –5,663; 
adjusted β, –
$1,423; CI, –
$2,574 to –272; p 
value is equal to 
0.015 
Levy et al., 2018 
 
The Surviving 
Sepsis Campaign 
Bundle: 2018 
update 
Clinical 
Practice 
Guideline  
 
Level I  
N/A To provide an 
update to the 2016 
Surviving Sepsis 
Campaign 
Guidelines for 
Management of 
Sepsis and Septic 
Shock. 
Use of grading 
recommendations 
assessment, 
development and 
evaluation system 
to guide 
assessment of 
quality evidence. 
• Measure lactate 
level within one 
hour of sepsis 
recognition. Re-
measure if initial 
lactate is > 2 
mmol/L – Weak 
recommendation. 
Low quality of 
evidence 
• Obtain blood 
cultures prior to 
administration of 
antibiotics – Best 
practice statement 
• Administer broad-
spectrum 
antibiotics within 
one hour of sepsis 
recognition – 
Strong 
recommendation, 
moderate quality of 
evidence 
• Rapidly administer 
30 ml/kg 
crystalloid for 
hypotension or 
lactate  4 mmol/L 
within one hour of 
sepsis recognition – 
Strong 
recommendation, 
low quality of 
evidence 
• Apply vasopressors 
if patient is 
hypotensive during 
or after fluid 
resuscitation to 
maintain MAP  65 
mmHg – Strong 
recommendation, 
moderate quality of 
evidence 
• Sepsis is a 
medical 
emergency, 
similar to stroke 
and polytrauma, 
that necessitates 
prompt 
recognition and 
treatment 
initiation 
• Elements of the 
updated 2018 
bundle should be 
implemented 
within one of 
sepsis 
recognition 
Levy et al., 2014 
 
Surviving Sepsis 
Campaign: 
association 
between 
performance 
metrics and 
outcomes in a 
7.5-year study 
Prospective 
observational 
cohort study  
 
Level IV 
29,470 subjects 
entered into 
SSC database 
between 
01/2005-
06/2012 at 218 
community, 
academic, and 
tertiary care 
hospitals in the 
United States.  
 
Compliance 
was defined as 
evidence that all 
bundle elements 
achieved. 
Primary: 
• Associated 
mortality rates  
Secondary: 
• SSC bundle 
compliance 
• Length of 
hospital and 
ICU stay 
 
Compliance was 
defined as 
evidence that all 
bundle elements 
achieved. 
• Overall lower 
mortality was 
observed in high 
(29.0 %) versus 
low (38.6 %) 
resuscitation 
bundle compliance 
sites (p < 0.001) 
and between high 
(33.4 %) and low 
(32.3 %) 
management 
bundle compliance 
sites (p = 0.039) 
• Hospital mortality 
rates dropped 0.7 % 
per site for every 3 
• Increase 
compliance with 
sepsis 
performance 
bundles was 
associated with a 
25% relative risk 
reduction in 
mortality  
• Performance 
metrics can 
improve quality 
of care, clinical 
behavior, and 
may reduce 
sepsis-related 
mortality  
 31 
months (quarter) of 
participation (p < 
0.001) 
• Hospital and 
intensive care unit 
length of stay 
decreased 4 % (95 
% CI 1–7 %; p = 
0.012) for every 10 
% increase in site 
compliance with 
the resuscitation 
bundle 
Novosad et al., 
2016 
 
Vital Signs: 
Epidemiology of 
Sepsis: 
Prevalence of 
Health Care 
Factors and 
Opportunities for 
Prevention 
Retrospective 
chart review  
 
Level VI 
Medical records 
of 246 adults 
and 79 children 
(aged birth to 
17) at four New 
York Hospitals. 
To describe the 
demographics, 
clinical 
characteristics, 
underlying chronic 
conditions, and 
infection types 
among patients 
with sepsis. 
• 72% of patients had 
a health care factor 
during the 30 days 
before sepsis 
admission or a 
chronic co-
morbidity that 
required frequent 
medical care  
• 25% (n=82) died, 
26% of these 
deaths (n=65) were 
65 or older and 
22% were infants 
and children (n=27) 
• Most common 
pathogen in blood 
cultures of adults  
18 years– 
Escherichia coli; of 
children  1 year – 
Klebsiella spp.; of 
infants < 1 year – 
Enterococcus 
• Most common 
illness that leads to 
sepsis – pneumonia 
35% (n=85) 
• Patients with sepsis 
experience severe 
illness and poor 
outcomes including 
longer: hospital 
stays 
(median=10days), 
discharge to long-
term settings (20%) 
and mortality 
(25%) 
Five key sepsis 
prevention strategies 
include: 
1. Increasing sepsis 
awareness among 
the public and 
professional 
communities 
2. Promoting early 
recognition of 
sepsis and 
administering 
antibiotics as 
soon as possible  
3. Identifying at-
risk populations  
4. Developing 
better sepsis 
surveillance 
methods 
5. Preventing 
infections that 
lead to sepsis 
Rhodes et al., 
2017 
 
Surviving Sepsis 
Campaign: 
International 
Guidelines for 
Management of 
Sepsis and Septic 
Shock: 2016 
Clinical practice 
guideline  
 
Consensus 
committee of 55 
international 
experts 
representing 25 
international 
organizations. 
 
Level I 
N/A To provide an 
update to the 2012 
Surviving Sepsis 
Campaign 
Guidelines for 
Management of 
Sepsis and Septic 
Shock. 
Use of Grading 
Recommendations 
Assessment, 
Development and 
Evaluation system 
to guide 
The Surviving Sepsis 
Guideline panel 
provided 93 states on 
early management and 
resuscitation of 
patients with sepsis or 
septic shock including: 
• 32 strong 
recommendations 
• 39 weak 
recommendations 
• 18 best practice 
statements 
• Four questions 
were left 
unaddressed 
Sepsis and septic 
shock are medical 
emergencies for 
which treatment and 
resuscitation should 
begin immediately 
Hospitals and 
hospital systems are 
recommended to 
have a performance 
improvement 
program for sepsis, 
including sepsis 
screening for acutely 
ill, high-risk patients 
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assessment of 
quality evidence. 
Serafim, Gomes, 
Salluh, & Póvoa, 
2018  
 
A Comparison of 
the Quick-SOFA 
and Systemic 
Inflammatory 
Response 
Syndrome 
Criteria for the 
Diagnosis of 
Sepsis and 
Prediction of 
Mortality 
Systematic 
review and 
meta-analysis of 
observation 
studies  
 
Level III 
10 prospective 
observational 
studies (n=229, 
480). 
 
Data extracted 
by two 
independent 
authors from 
02/2016-
7/2017. 
 
Exclusion 
criteria: data 
described about 
specific 
populations and 
case studies. 
Comparing the 
sensitivity and 
specificity in 
diagnosing sepsis, 
hospital length of 
stay, and mortality 
of qSOFA and 
SIRS in patients 
outside the ICU. 
• Sensitivity for the 
diagnosis of sepsis 
was in favor of 
SIRS (risk ratio 
[RR], 1.32; 95 % 
Cl, 0.40-2.24; p < 
0.0001) 
• Comparing the 
qSOFA and SIRS 
score, the qSOFA 
is a better predictor 
of in-hospital 
mortality (risk ratio 
[RR], 0.03 95 % 
Cl, 0.02-0.05k; 
P=0.002) 
• One-year mortality 
for patients who 
met qSOFA criteria 
was higher that of 
SIRS criteria (RR, 
29.4; 95 % Cl, 
22.3-38.7 vs 14.7; 
95 % Cl, 12.5-17.2) 
• The SIRS is 
significantly 
superior for 
sepsis diagnosis  
• The qSOFA is 
better at 
predicting 
hospital mortality 
than the SIRS 
• Quality 
improvement 
initiatives should 
include both 
criteria, which 
could improve 
early sepsis 
recognition and 
reduce the 
development of 
septic shock 
Seymour et al., 
2016 
 
Assessment of 
Clinical Criteria 
for Sepsis: For 
the Third 
International 
Consensus 
Definitions for 
Sepsis and Septic 
Shock (Sepsis-3) 
Retrospective 
cohort study 
 
Level IV 
Primary cohort: 
All hospital 
encounters of 
adult patients 
(age  18 years) 
with sepsis 
infection at 12 
community and 
academic 
hospitals in 
southwestern 
Pennsylvania 
from 2010-2012 
(n=148,907). 
 
Primary cohort 
randomly split 
(50/50) for 
derivation 
(n=74,453) and 
validation 
cohort 
(74=454). 
 
Confirmatory 
analysis: Out-
of-hospital 
encounters and 
hospital 
encounters at 
165 U.S and 
non-U.S. 
hospitals from 
01/2008-2013 
extracted from 
4 data sets. 
To evaluate the 
validity of clinical 
criteria to identify 
patients with 
suspected infection 
who are at risk for 
sepsis: 
• Systemic 
Inflammatory 
Response 
Syndrome 
(SIRS) 
• Sequential 
Organ Failure 
Assessment 
(SOFA) 
• Quick 
Sequential 
Organ Failure 
Assessment 
(qSOFA) 
• Logistic Organ 
Dysfunction 
System 
(LODS) score 
 
Primary: 
• In-hospital 
mortality 
• Secondary: 
• ICU length of 
stay  3 days 
 
 
• Primary cohort - 
6347 (4%) deaths 
• Validation cohort 
ICU (n = 7932 with 
suspected 
infection) 1289 
(16%) deaths 
• Predictive validity 
for in-hospital 
mortality was lower 
for SIRS (AUROC 
= 0.64; 95% CI, 
0.62–0.66) and 
qSOFA (AUROC = 
0.66; 95% CI, 
0.64–0.68) vs 
SOFA (AUROC = 
0.74; 95% CI, 
0.73–0.76; P <. 001 
for both) and 
LODS (AUROC = 
0.75; 95% CI, 
0.73–0.76; P < .001 
for both) 
• Validation cohort 
non-ICU (n = 66 
522 with suspected 
infection) 1886 
(3%) deaths 
• qSOFA had 
predictive validity 
(AUROC = 0.81; 
95% CI, 0.80–0.82) 
that was greater 
than SOFA 
(AUROC = 0.79; 
95% CI, 0.78–0.80; 
P < .001) and SIRS 
(AUROC = 0.76; 
95% CI, 0.75– 
0.77; P < .001) 
• In the ICU, the 
predictive 
validity for in-
hospital mortality 
of SOFA was 
statistically 
greater than SIRS 
and qSOFA, 
supporting its use 
in clinical criteria 
for sepsis 
• Outside of the 
ICU, the 
predictive 
validity for in-
hospital mortality 
of qSOFA was 
statistically 
greater than 
SOFA and SIRS, 
supporting its use 
as a prompt to 
consider possible 
sepsis 
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• Relative to qSOFA 
scores lower than 2, 
encounters with 
qSOFA scores of 2 
or higher had a 3- 
to 14-fold increase 
in hospital 
mortality across 
baseline risk 
deciles. Findings 
were similar in 
external data sets 
and for the 
secondary outcome 
Singer et al., 
2016 
 
The Third 
International 
Consensus 
Definitions for 
Sepsis and Septic 
Shock (Sepsis-3) 
Expert opinion, 
review of 
literature 
 
Level VII 
N/A To evaluate and 
update definitions 
for sepsis and 
septic shock.   
Limitations of 
previous definitions 
included: 
• Excessive focus of 
inflammation 
• Mislead model of 
sepsis as a 
continuum to 
severe sepsis to 
shock 
• Inadequate 
specificity and 
sensitivity of the 
SIRS criteria 
 
Multiple definitions 
and terminologies lead 
to discrepancies in 
reporting incidence 
and mortality. 
• Sepsis should be 
defined as life-
threatening organ 
dysfunction by a 
dysregulated host 
response to 
infection 
• Organ 
dysfunction can 
be represented by 
an increase in the 
Sequential 
[Sepsis-related] 
Organ Failure 
Assessment 
(SOFA) score of 
2 points or more, 
which is 
associated with 
an in-hospital 
mortality greater 
than 10% 
• Septic shock 
should be defined 
as a subset of 
sepsis in which 
particularly 
profound 
circulatory, 
cellular, and 
metabolic 
abnormalities are 
associated with a 
greater risk of 
mortality than 
with sepsis alone  
• Septic shock can 
be clinically 
identified by a 
vasopressor 
requirement to 
maintain a mean 
arterial pressure 
of 65 mmHg or 
greater and 
serum lactate 
level greater than 
2 mmol/L (>18 
mg/dL) in the 
absence of 
hypovolemia  
Teles et al., 2017 
 
Observational 
retrospective 
study  
167 patients 
were 
retrospectively 
To assess the 
impact of a sepsis 
protocol on the 
• Overall mortality: 
31.1% 
The use of a sepsis 
protocol was 
associated with 
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Impact of a 
sepsis bundle 
inwards of a 
tertiary 
hospital. Journal 
of Intensive Care 
 
Level III 
studied at Sana 
Casa de 
Misericordia de 
Maceió 
Hospital 
 
Data collection 
from 01/2012-
12/2013. 
outcomes of 
patients inwards of 
a tertiary hospital.  
 
3-hour bundle 
consisted of:  
• Collecting 
lactate and 
cultures 
• Start broad-
spectrum 
antibiotics in 
the first hour of 
sepsis diagnosis 
• Volume 
replacement 
with crystalloid 
if hypotension 
presents of 
lactate  2 
mmol/L 
• Individuals who 
received the 3-hour 
bundle showed a 
44% lower 
mortality in 
comparison with 
who did not (25.6 
vs. 45.7%; p = 
0.01) and shorter 
length of stay in 
ICU (9.0 ± 5.90 
versus 4.6 ± 6.20 
days; p < 0.0001) 
• Greater frequency 
of ICU admissions 
in patients who did 
not receive the 
bundle (28.3 versus 
15.8%; p = 0.06) 
• Sepsis bundle was 
independently 
correlated with 
lower mortality 
(OR = 0.175; CI = 
0.04–0.64; p = 
0.009) 
lower mortality, 
reduced ICU 
admission, and 
shorter ICU stays  
Torsvik et al., 
2016 
 
Early 
identification of 
sepsis in hospital 
inpatients by 
ward nurses 
increases 30-day 
survival 
Before-and-
after 
intervention 
study  
 
Level IV 
Emergency 
room of a 124-
bed community 
hospital in 
Norway.  
 
Patients with 
confirmed 
bloodstream 
infections 
(BSI). 
 
Pre-intervention 
group: 01/2008-
12/2010 
(n=422). 
 
Post-
intervention 
group: 10/2011-
12/201 (n=409). 
To investigate 
whether 
implementation of 
a clinical tool for 
triage of SIRS and 
organ failure, an 
alert, and treatment 
flow chart could 
improve clinical 
observations, lead 
to fewer patients 
developing severe 
sepsis, and thus 
improve in-
hospital. 
The post-intervention 
group had higher odds 
of surviving 30 days 
(OR 2.7, 95 % CI 1.6, 
4.6), lower probability 
of developing severe 
organ failure (0.7, 95 
% CI 0.4, 0.9), and on 
average, 3.7 days (95 
% CI 1.5, 5.9 days) 
shorter LOS than the 
pre-intervention group. 
Early sepsis 
recognition by ward 
nurses may reduce 
progression and 
improve survival of 
patients with sepsis. 
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APPENDIX B – Report of Findings  
  
 
 
Summary of Evidence  
Sepsis and septic shock are medical emergencies that are similar to stokes and 
polytrauma, which necessitate prompt identification and treatment initiation (Lester et al., 
2018; Levy et al., 2018; Rhodes et al., 2017).  In 2018, the SSC updated the three-hour 
and six-hour bundles to incorporate new evidence, which now includes one bundle to be 
initiated within one-hour of sepsis recognition (Lester et al., 2018; Levy et al., 2018).  In 
a recent study conducted over five years (N =1,060) that evaluated lactate levels as a 
predictor of mortality, higher levels of serum lactate were recorded from subjects who did 
2012 Surviving Sepsis Campaign 
Guidelines  
Three Hour Bundle 
1. Measure lactate level 
2. Obtain blood cultures prior to 
administration of antibiotics  
3. Administer broad-spectrum 
antibiotics  
4. Administer 30 mL/kg of IV 
crystalloid for hypotension or lactate 
 4 mmol/L  
Six Hour Bundle 
5. Apply vasopressors to maintain a 
MAP  65 mmHg.  
6. Reassessment of volume status and 
tissue perfusion with documentation 
of findings if hypotension persists 
after initial fluid volume 
replacement or the initial lactate was 
 4 mmol/L.  
7. Re-measure of lactate if initial 
lactate was elevated  
2018 Surviving Sepsis Campaign 
Guidelines  
One Hour Bundle  
1. Measure lactate level.  
2. Obtain blood cultures prior to 
administration of antibiotics.  
3. Administer broad-spectrum 
antibiotics.  
4. Begin rapid administration of 30 
mL/kg of crystalloid for 
hypotension or lactate  to 4 
mmol/L.  
5. Apply vasopressors if patient is 
hypotensive during or after fluid 
resuscitation to maintain MAP  65 
mmHg.  
6. Frequent hemodynamic 
reassessments of patient’s fluid 
status through noninvasive 
measurements including vital sign 
assessment; cardiopulmonary, 
capillary refill, pulse, and skin 
findings; or bedside cardiovascular 
ultrasound; 
7. Re-measure of lactate if initial 
lactate was elevated  
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not survive (Ryoo et al., 2018).  A systematic review and meta-analysis consisting of 10 
quantitative studies published between 1990 and 2016 were conducted to determine the 
effect of antimicrobial administration on sepsis patients in tertiary care.  This review 
reported a 33% reduction in mortality odds for patients who received IV antibiotics 
within one hour of sepsis recognition compared to the population who experienced 
detailed administration (OR, 0.67 [95% CI, 0.59-0.75]) (Johnston et al., 2017).  
Additionally, in a retrospective cohort study completed at a 656-bed medical institution 
(N =3,929) to determine the effects of initial antimicrobial administration with the 
progression of septic shock, each hour that antimicrobial administration was delayed 
associated with an 8% increase in progression of septic shock (Whiles, Deis, & Simpson, 
2017).  In an observational cohort study conducted over a 13-month period (N =1800) to 
determine the effects of early fluid resuscitation on mortality, early initiation of fluid 
administration was associated with a reduction in mortality for severe sepsis and septic 
shock patients (OR 0.63; 95% CI 0.46 to 0.86) (Leisman et al., 2016). 
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APPENDIX C – Evaluation Tool  
Sepsis Quality Improvement Evaluation Tool 
The University of Southern Mississippi  
 
Participation in this questionnaire is voluntary. There are no repercussions for non-
participation, and you may elect to discontinue completion at any time. Thank you 
for your time and help. 
 
Do you consent to participate in this study?     YES  NO 
 
Please rate the following questions by circling your answer.  
 
1. Is this presentation regarding the 2018 guidelines for sepsis management new 
to you?           
    YES  NO 
 
2. Was the information provided beneficial?  
 
Strongly  Disagree Neutral Agree  Strongly 
Disagree        Agree 
 
3. Is the information provided relevant to your institution?  
 
Strongly  Disagree Neutral Agree  Strongly 
Disagree        Agree 
 
 
4. Would you consider adopting this best practice?   
 
YES  NO   
 
5. Comment/concerns:  
            
           
           
           
           
            
 
Thank you for your time and consideration.  
 
Austin Williams, SRNA 
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APPENDIX D – IRB Approval Letter 
  
 
 
June 8, 2018 
To Whom It May Concern,  
 I have reviewed the IRB Application of Austin Williams (“Implementation of an Evidence-
Based Adult Sepsis Guideline”) and have determined that IRB review and approval of this project 
is not required, given the nature of the data to be used.   
 If you have question about this, please contact me.   
Sincerely,  
 
Sam Bruton, Director 
Samuel.Bruton@usm.edu 
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APPENDIX E – Letter of Support  
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APPENDIX F – DNP Essentials  
Doctor of Nursing Essentials How the Essential is Achieved 
I. Scientific Underpinning for Practice A review of current literature for the best 
practice of early adult sepsis management 
was performed.  The information gathered 
was utilized to provide best practice 
recommendations for this DNP project.    
II. Organizational and Systems 
Leadership for Quality 
Improvement and System Thinking 
This doctoral project sought to improve 
quality through determining best practice 
recommendations for early adult sepsis 
management that was presented to a panel 
of experts that would review the 
recommendations and disseminate the 
information provided.   
III. Clinical Scholarship and Analytical 
Methods for Evidence-Based 
Practice 
This essential was met by performing an 
extensive literature review on the current 
evidence-based practice for early sepsis 
management in the adult population.   
IV. Health Care Policy for Advocacy in 
Health Care 
This project leads to the potential 
improvement of a clinical practice 
guideline for management of adult 
patients with sepsis.  
V. Health Care Policy for Advocacy in 
Health Care  
This essential was met by determining 
current best practice recommendations for 
early adult sepsis management that could 
be utilized for implementation of a new 
institutional policy.   
VI. Interprofessional Collaboration for 
Improving Patient and Population 
Health Outcomes 
This project utilized effective 
communication between and members of 
an expert panel. Through completing this 
project, the dissemination of current 
evidence was accomplished that could be 
used for practice improvements.   
VII. Clinical Prevention and Population 
Health for Improving the Nation’s 
Health  
This essential was met by increasing 
awareness of potential measures to 
improve care provided to adult patients 
with sepsis.   
VIII. Advanced Nursing Practice The best practice project was ultimately 
aimed at utilizing best practice 
recommendations to develop to improve 
an existing clinical practice guideline.   
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